Overview Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients Status: Completed Trial end date: 2006-04-01 Target enrollment: Participant gender: Summary This study will assess the effects of single oral doses of SB681323 and prednisolone on biomarkers in induced sputum and blood COPD patients Phase: Phase 1 Details Lead Sponsor: GlaxoSmithKlineTreatments: MethylprednisoloneMethylprednisolone acetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate